2019 SPEAKERS

 

These speakers are confirmed to present across both World Vaccine Congress & Immune Profiling Congress Washington

Dr Dicky Abraham, Executive Director/Distinguished Scientist, Merck

Dr Olutola Adetona, Physician /PI/ Director of Pediatrics, Tekton Research

Mashal Almutairi, Assistant Professor Of Pharmaceutical Biotechnology, King Saud university and Baylor College of Medicine

Mashal Almutairi | Assistant Professor Of Pharmaceutical Biotechnology | King Saud university and Baylor College of Medicine » speaking at Immune Profiling Congress

Galit Alter, Associate Professor Of Medicine, Harvard Medical School

Galit Alter | Associate Professor Of Medicine | Harvard Medical School » speaking at Immune Profiling Congress

Carl Alving, Former Chief Of Adjuvant And Antigen Research And Emeritus Senior Scientist, Walter Reed Army Institute Of Research

Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines and the Hospital Business Unit, Pfizer, Pfizer

Dr David Anderson, Chief Scientific Officer, VBI Vaccines

Dr Bo Arve, Executive Director, Pfizer

Dr Bo Arve | Executive Director | Pfizer » speaking at Immune Profiling Congress

Dr Jessica Atwell, International Health, Global Disease Epidemiology and Control, Johns Hopkins Bloomberg School of Public Health

Dr Jessica Atwell | International Health, Global Disease Epidemiology and Control | Johns Hopkins Bloomberg School of Public Health » speaking at Immune Profiling Congress

Greg Babcock, Vice President, Research, Visterra Inc.

Greg Babcock | Vice President, Research | Visterra Inc. » speaking at Immune Profiling Congress

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences

Dr Monika Ballmann, Bioprocess scientist, Batavia Biosciences

Rip Ballou, Vice President And Head Of Global Vaccines, Research And Development Center, GSK

Dan Barouch, Professor Of Medicine, Harvard Medical School

Dan Barouch | Professor Of Medicine | Harvard Medical School » speaking at Immune Profiling Congress

Dr Mario Barro, AVP and Head of FluNXT Advanced Research, Sanofi Pasteur

John Barry, Chief Operating Officer, Pharm-Olam

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories

Wolfgang Bender, Chief Medical Officer, Valneva

Jason Berg, Director, Project Management, PPD

Jason Berg | Director, Project Management | PPD » speaking at Immune Profiling Congress

Miguel Betancourt-Cravioto, Director For Global Solutions, Carlos Slim Foundation

Miguel Betancourt-Cravioto | Director For Global Solutions | Carlos Slim Foundation » speaking at Immune Profiling Congress

Dr Prakash Bhuyan, Vice President, Clinical Development, Inovio

Lisa Bielke, Assistant Professor, Ohio State University

Lisa Bielke | Assistant Professor | Ohio State University » speaking at Immune Profiling Congress

Zachary Bornholdt, Director, Antibody Discovery, Mapp Biopharmaceuticals

Zachary Bornholdt | Director, Antibody Discovery | Mapp Biopharmaceuticals » speaking at Immune Profiling Congress

Steven Bosinger, Assistant Professor, Emory School of Medicine

Steven Bosinger | Assistant Professor | Emory School of Medicine » speaking at Immune Profiling Congress

Reinhard Braun, Chief Executive Officer, Pantec Biosolutions

Dr Grayson Brown, Executive Director Of The Puerto Rico Vector Control Unit, CDC

Cindy Burnsteel, Supervisory Veterinary Medical Officer, Food and Drug Administration

Lynlee Burton, Director Of Project Delivery - Vaccines, PRA Health Sciences

Dr Wendy Carr, Acting Design And Oversight Team Lead Clinical Research Branch, US Centers for Disease Control and Prevention

Dr Wendy Carr | Acting Design And Oversight Team Lead Clinical Research Branch | US Centers for Disease Control and Prevention » speaking at Immune Profiling Congress

Arturo Casadevall, Chairman Of Molecular Microbiology And Immunology, Johns Hopkins Bloomberg School of Public Health

Arturo Casadevall | Chairman Of Molecular Microbiology And Immunology | Johns Hopkins Bloomberg School of Public Health » speaking at Immune Profiling Congress

Dr Danilo Casimiro, Vice President And Head, External RAndD And Vaccine Platforms, Sanofi Pasteur

Dr Corey Casper, Chief Scientific Officer, Infectious Disease Research Institute

Cristina Cassetti, Branch Chief Virology Branch Division Of Microbiology And Infectious Diseases, National Institutes of Health (NIH)

Dr Rebecca Chandler, Research Physician, Uppsala Monitoring Centre - WHO Collaborating Centre for International Drug Monitoring

Daniel Chen, Former Vice President And Global Head Of Cancer Immunotherapy Development, Genetech

Daniel Chen | Former Vice President And Global Head Of Cancer Immunotherapy Development | Genetech » speaking at Immune Profiling Congress

Dr Daniel Chen, Former Vice President And Global Head Of Cancer Immunotherapy Development, Genentech; Cmo, IgM. Biosciences Inc

Dr Kc Cheng, Senior Director - Analytical And Formulation Development, V.P.P. V.R.C. N.I.A.I.D. N.I.H.

Roman Chicz, Associate Vice President And Global Head Of External Research And Development, Sanofi Pasteur

Rachel Clemens, Commercial Innovation Manager, International Space Station US National Laboratory

Rachel Clemens | Commercial Innovation Manager | International Space Station US National Laboratory » speaking at Immune Profiling Congress

Dr Jeffrey Cohen, Chief Of Laboratory Of Infectious Diseases, NIH

Dr Nick Conley, Principal Scientist, Locus Biosciences

Dr Nick Conley | Principal Scientist | Locus Biosciences » speaking at Immune Profiling Congress

Lisa Conti, Co-Founder, One Health Initiative

Dr Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Larry Corey, President And Director Emeritus, Fred Hutchinson Cancer Research Center

Larry Corey | President And Director Emeritus | Fred Hutchinson Cancer Research Center » speaking at Immune Profiling Congress

Rodrigo Correa-Oliveira, Senior Scientist, Fiocruz

Rodrigo Correa-Oliveira | Senior Scientist | Fiocruz » speaking at Immune Profiling Congress

James Crowe, Director Of Vanderbilt Vaccine Center, IDBiologics

Dr Ildiko Csiki, CMO, Sensei Bio

Dr James Cummings, President, ICON Government & Public Health Solutions

Dame Sally Davies, Chief Medical Officer, Department of Health

Dame Sally Davies | Chief Medical Officer | Department of Health » speaking at Immune Profiling Congress

Steve Davis, President And Chief Executive Officer, Path

Wian De Jongh, Chief Scientific Officer, ExpreS2ion Biotechnologies

Wian De Jongh | Chief Scientific Officer | ExpreS2ion Biotechnologies » speaking at Immune Profiling Congress

Dr Michel De Wilde, Former Senior Vice President R&D of Sanofi Pasteur & Owner, MDW Consultant LLC

Katherine Deland, Chief Of Staff, Ebola Response, World Health Organisation

Philippe Denoel, Director Of External Research and Development, Innovation, Scientific Affairs And Opportunities Collaborations For Public Fundin, GSK Vaccines

Philippe Denoel | Director Of External Research and Development, Innovation, Scientific Affairs And Opportunities Collaborations For Public Fundin | GSK Vaccines » speaking at Immune Profiling Congress

Aparna Deora, Senior Director, ARD, QCSM, Pfizer

Frank Derosa, Senior Vice President, Translate Bio

Frank Derosa | Senior Vice President | Translate Bio » speaking at Immune Profiling Congress

Arnaud Didierlaurent, Head Adjuvant Platform, GSK Vaccines

Arnaud Didierlaurent | Head Adjuvant Platform | GSK Vaccines » speaking at Immune Profiling Congress

Carl Dieffenbach, Director, Division of AIDS, NIAID, NIH

Carl Dieffenbach | Director, Division of AIDS, NIAID | NIH » speaking at Immune Profiling Congress

David Diemert, Associate Professor, The George Washington University

David Diemert | Associate Professor | The George Washington University » speaking at Immune Profiling Congress

Patrick Duffy, Chief of Pathogenesis and Immunity Section, National Institutes of Health

Cynthia Dukes, Vice President, Drug Development, Rare Disease, ICON plc

Anna Durbin, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Laurent Duroux, Senior Scientist, Brenntag As

Laurent Duroux | Senior Scientist | Brenntag As » speaking at Immune Profiling Congress

Joseph Eiden, Senior Medical Consultant, FluGen Inc

Joseph Eiden | Senior Medical Consultant | FluGen Inc » speaking at Immune Profiling Congress

Barry Eisenstein, Chair, Scientific Advisory Board, CARB-X

Barry Eisenstein | Chair, Scientific Advisory Board | CARB-X » speaking at Immune Profiling Congress

Gary Eldridge, President And Chief Executive Officer, Sequoia Sciences Inc

Gary Eldridge | President And Chief Executive Officer | Sequoia Sciences Inc » speaking at Immune Profiling Congress

Jon Epstein, Vice President For Science And Outreach, Ecohealth Alliance Inc.

Mark Esser, Senior Director, Vaccines And Infectious Diseases, Translational Medicine, MedImmune Inc

Dr Brandon Essink, Medical Director, Meridian Clinical Research

Dr Ester Falconer, Group Leader, AbCellera Biologics Inc

Mark Feinberg, Chief Executive Officer & President, IAVI

Professor Dean Felsher, Professor Medicine-Oncology And Pathology, Stanford University School of Medicine

Rohan Fernandes, Assistant Professor, The George Washington University

Rohan Fernandes | Assistant Professor | The George Washington University » speaking at Immune Profiling Congress

Ana Fernandez-Sesma, Professor, Mount Sinai

Ana Fernandez-Sesma | Professor | Mount Sinai » speaking at Immune Profiling Congress

Allison Flinn, Lead, North America Public Policy, Merck Animal Health

Allison Flinn | Lead, North America Public Policy | Merck Animal Health » speaking at Immune Profiling Congress

Dr Silvia Formenti, Chairman Of The Department Of Radiation Oncology, Radiation Oncologist Chief, Associate Director, Meyer Cancer Institute, Weill Cornell Medical College

Leonard Friedland, Vice President, Scientific Affairs And Public Health Vaccines, North America, GSK

Dr Luc Gagnon, Chief Scientific Officer, NEOMED-LABS

Dr Luc Gagnon | Chief Scientific Officer | NEOMED-LABS » speaking at Immune Profiling Congress

Dr Nathalie Garcon, Chief Executive Officer And Chief Scientific Officer, BIOASTER

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Richard Gaynor, President Of Research And Development, Neon Therapeutics

Rebecca Gentile, Associate Director, Quality Vaccine And Biological Stability, Merck

George Georgiou, Professor, The University of Texas At Austin

George Georgiou | Professor | The University of Texas At Austin » speaking at Immune Profiling Congress

Volker Gerdts, Director & CEO, VIDO-InterVac

Dr Brad Gessner, Vice President, Medical and Scientific Affairs, AMP; Vice President, Global Medical Lead for Pneumococcal Vaccines, Pfizer

Basav Ghosh, Senior Director, Pfizer

Brett Giroir, Assistant Secretary For Health, U.S. Department of Health & Human Services

Douglas Gladue, Senior Scientist, Plum Island Animal Disease Center, USDA

Gregory Glenn, President, Research And Development, Novavax

Jennifer Gordon, Program Officer Influenza Vaccine Development, National Institute of Allergy and Infectious Diseases

Jennifer Gordon | Program Officer Influenza Vaccine Development | National Institute of Allergy and Infectious Diseases » speaking at Immune Profiling Congress

Barney Graham, Deputy Director Of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

Simon Graham, Group Leader, Prrs Immunology, The Pirbright Institute

Dr Beth Ann Griswold-Coller, Executive Director Of Project Leadership And Management, Merck

Marion Gruber, Director Of Office For Vaccines, FDA

Marion Gruber | Director Of Office For Vaccines | FDA » speaking at Immune Profiling Congress

Duane Gubler, Emeritus Professor, Programme In Emerging Infectious Diseases, Duke-NUS Graduate Medical School

Dr Dario Gutierrez, Director And Head Of Investigational Biology, Merck Exploratory Science Center

Henk Haagsman, Professor Of Molecular Host Defence, Head Department Of Infectious Diseases And Immunology, Utrecht University

Tara Haelle, Author of Vaccination Investigation: The History and Science of Vaccines, Co-author of The Informed Parent: A Science-Based Reso, Science Journalist & Author

Dr Jason Hamilton, Senior Director, Manufacturing & Development, Legend Biotech

Dr Jason Hamilton | Senior Director, Manufacturing & Development | Legend Biotech » speaking at Immune Profiling Congress

Nick Hamon, Chief Executive Officer, IVCC

Nick Hamon | Chief Executive Officer | IVCC » speaking at Immune Profiling Congress

Paddy Hanlon, Vice President, Commercial Operations, Marken

Dr Emmanuel Hanon, Senior Vice President, Head Of Vaccines Research and Development, GSK Vaccines

Dr Christopher Heery, Chief Medical Officer, Bavarian Nordic

Charles Heffernan, Former Supply Chain Transformation And Technology Innovation Lead, Gsk And Member, BioPhorum Operations Group

Jon Heinrichs, Associate Vice President and Segment Head, Sanofi Pasteur

Dr Jenny Hendriks, Head Biomarkers, Janssen Infectious Diseases and Vaccines

Matthew Henn, Senior Vice President, Head Of Drug Discovery And Bioinformatics, Seres Therapeutics

Matthew Hepburn, D.A.R.P.A.

Matthew Hepburn |  | D.A.R.P.A. » speaking at Immune Profiling Congress

Andy Hillier, Medical Lead Dermatology And Allergy, Veterinary Specialty Operations, Zoetis

Dr Tim Hirst, Chairman & CEO, GPN Vaccines

Marc Hoffman, Chief Medical Officer, Celerion

Scott Holmstrom, Senior Director, Global Product Development, Elanco Animal Health

David Hone, Chief Scientist, Vaccine And Therapeutic Division, Joint Science And Technology Office, Defense Threat Reduction Agency

David Hone | Chief Scientist, Vaccine And Therapeutic Division, Joint Science And Technology Office | Defense Threat Reduction Agency » speaking at Immune Profiling Congress

Peter Hotez, Dean, National School Of Tropical Medicine, Director, Texas Children?S Hospital Center, Baylor College of Medicine

Randall Hyer, Vice President, Clinical Development And Medical Affairs, Dynavax

Darrell Irvine, Professor Of Materials Science, Engineering And Biological Engineering, Massachusetts Institute of Technology

Dr Steven Jacobsen, Senior Director Of Research, Kaiser Permanente Southern California

Dr Richard Kennedy, Professor Of Medicine, Co-Director, Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Amit Khandhar, Formulation Lead, Infectious Disease Research Institute

Dr Amit Khandhar | Formulation Lead | Infectious Disease Research Institute » speaking at Immune Profiling Congress

Peter Khoury, Chief Executive Officer, Ology Bioservices

Jerome Kim, Director-General, International Vaccine Institute

Dr Nikole Kimes, President And Chief Scientific Officer, Siolta Therapeutics

Harry Kleanthous, Associate Vice President, Head Of Research, North America, Sanofi Pasteur

Norbert Klein, Vice President, Head Of Manufacturing Science And Technology (Msat), GSK

Steven Kleinstein, Associate Professor Of Pathology, Yale University

Dr John Knighton, Vice President of A.P.I. Large Molecule Development, Janssen Research & Development, LLC

Dr John Knighton | Vice President of A.P.I. Large Molecule Development | Janssen Research & Development, LLC » speaking at Immune Profiling Congress

Sarah Kobrin, Branch Chief, NIH

Wayne Koff, President And Chief Executive Officer, The Human Vaccines Project

Dr Alexander Koglin, Co-Founder, NTxBio

Bette Korber, Laboratory Fellow, Los Alamos National Laboratory

Bette Korber | Laboratory Fellow | Los Alamos National Laboratory » speaking at Immune Profiling Congress

Dr Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience GmbH

Martina Kovac, Vaccine Development Leader-Maternal Immunization, GSK

Martina Kovac | Vaccine Development Leader-Maternal Immunization | GSK » speaking at Immune Profiling Congress

Dr Richard C Koya, Chief Scientific Officer, Tactiva Therapeutics

Philip Krause, Deputy Director, U.S. Food and Drug Administration

Philip Krause | Deputy Director | U.S. Food and Drug Administration » speaking at Immune Profiling Congress

Dr Christopher Kripas, Pharmacovigilance Head, Moderna Therapeutics

Dr Christopher Kripas | Pharmacovigilance Head | Moderna Therapeutics » speaking at Immune Profiling Congress

Mahesh Kumar, Senior Vice President, Global Biologics Research, Zoetis

Peter Kwong, Chief, Structural Biology Section, NIH

Tom Lake, Senior Vice President, Technology Development Alliances, Vaxxas

Carole Langlois, Manager, Marketing And Traditional Vaccines, Sartorius

Dr Cheryl Lapham, Program Officer, Basic Immunology Branch, NIAID, National Institutes of Health (NIH)

Shahram Lavasani, Founder And Chief Executive Officer, ImmuneBiotech Ab

Dr Julie Leask, Professor, Faculty of Medicine and Health, Adjunct A/Prof, School of Public Health, Visiting Fellow, National Centre for Immuniz, University of Sydney

Dr Julie Leask | Professor, Faculty of Medicine and Health, Adjunct A/Prof, School of Public Health, Visiting Fellow, National Centre for Immuniz | University of Sydney » speaking at Immune Profiling Congress

Dr Bruce Lee, Associate Professor Of International Health, Executive Director Of Gopc, Director Of Operations Of Ivac, Johns Hopkins Bloomberg School of Public Health

Andrew Lees, Scientific Director, Fina BioSolutions

Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Allergy and Infectious Diseases

Mike Levine, Grollman Distinguished Professor And Director, Center For Vaccine Development, University of Maryland School of Medicine

Mike Levine | Grollman Distinguished Professor And Director, Center For Vaccine Development | University of Maryland School of Medicine » speaking at Immune Profiling Congress

Dr Ofer Levy, Professor Of Pediatrics, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Dr Ed Lewin, Research Professor, Milken Institute For Public Health, Georgetown University School Of Medicine

Julia Li, Senior Director, Pfizer

Julia Li | Senior Director | Pfizer » speaking at Immune Profiling Congress

Dr Rupali Limaye, Associate Director, Behavioral Research, Institute Vaccine Safety, Johns Hopkins Bloomberg School of Public Health

Sarena Lin, Executive Vice President, Usa And Global Strategy, Elanco Animal Health

Sarena Lin | Executive Vice President, Usa And Global Strategy | Elanco Animal Health » speaking at Immune Profiling Congress

Dr Robert Lindblad, Medical Monitor, STRIVE Ebola Vaccine Trial

Dr Gerald P Linette, Professor of Medicine, Center for Cellular Immunotherapies, University of Pennsylvania

Thomas Lingelbach, President And Chief Executive Officer, Valneva

Dr Ke Liu, Chief, Oncology Branch, Acting Associate Director For Oncology Cell And Gene Therapy, Oncology Center Of Excellence, Food and Drug Administration

Dr Robert Loberg, Executive Director And Head Of Clinical Biomarkers And Diagnostics, Amgen

Dr Robert Loberg | Executive Director And Head Of Clinical Biomarkers And Diagnostics | Amgen » speaking at Immune Profiling Congress

Dr Mats Lundgren, Customer Applications Director, G.E. Healthcare

Nicole Lurie, Strategic Advisor To Ceo, C.E.P.I.

Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership

Michael Makanga | Executive Director | European and Developing Countries Clinical Trials Partnership » speaking at Immune Profiling Congress

Frank Malinoski, Chief Medical Officer, Eveliqure

Frank Malinoski | Chief Medical Officer | Eveliqure » speaking at Immune Profiling Congress

John Markels, President, Merck Vaccines

John Markels | President | Merck Vaccines » speaking at Immune Profiling Congress

John Mascola, Director-Vaccine Research Center, NIAID, NIH

Jonna Mazet, Professor Of Epidemiology And Disease Ecology And Executive Director Of The One Health Institute, U.C. Davis School of Veterinary Medicine

Karen Mccarthy, Senior Director Project Management, PPD

Karen Mccarthy | Senior Director Project Management | PPD » speaking at Immune Profiling Congress

Jason Mclellan, Assistant Professor, Geisel School of Medicine

Jason Mclellan | Assistant Professor | Geisel School of Medicine » speaking at Immune Profiling Congress

Dr Malte Meppen, Head of Drug Product Development, GSK

Michael Merchlinsky, Scientific Program Manager, HHS/BARDA

Michael Merchlinsky | Scientific Program Manager | HHS/BARDA » speaking at Immune Profiling Congress

Dr Tod Merkel, Professor Of Laboratory For Respiratory And Special Pathogens Division, Center for Biologics Evaluation and Research

Dr Stefano Messori, Chargé de mission, World Organisation for Animal Health

Wouter Meuleman, Director, Venture Investments, Illumina Ventures

Wouter Meuleman | Director, Venture Investments | Illumina Ventures » speaking at Immune Profiling Congress

Nelson Michael, Director Of M.H.R.P., Walter Reed Army Institute of Research

Thomas Monath, Managing Partner And Chief Scientific Officer, Crozet BioPharma LLC

Ruth Montgomery, Professor Of Medicine, Yale University

Ruth Montgomery | Professor Of Medicine | Yale University » speaking at Immune Profiling Congress

Emanuele Montomoli, Professor In Public Health University Of Siena And Chief Scientific Officer, VisMederi

Vasee Moorthy, Coordinator, Research, Ethics, Knowledge Uptake, Department Of Information, Evidence And Research, And Team Leader, Research and, World Health Organisation

Imraan Munshi, Executive Director and Global Communications Lead for Vaccines, Merck & Co Inc

Thomas Muster, Managing Director And Chief Scientific Officer, Vivaldi Biosciences Inc

Stephen Nagler, Executive Director, MedPro Investors Llc

Michael Nally, President Of Merck Vaccines, Merck

Michael Nally | President Of Merck Vaccines | Merck » speaking at Immune Profiling Congress

Robin Nandy, UNICEF

Robin Nandy |  | UNICEF » speaking at Immune Profiling Congress

Peter Nara, Chairman Emeritus, Biological Mimetics, Inc.

Dr Jennifer Nelson, Director Of Biostatistics And Senior Investigator, Kaiser Permanente Washington

Dr Andreas Neubert, Vice President Vaccines, IDT Biologika

David Noll, Director, Scientific Affairs, Tiber Creek Partners

Dr Robert Nordgren, Head of Research and Development, Curtiss Healthcare

Dr Katherine O'Brien, Executive Director, International Vaccine Access Center Professor, Global Disease Epidemiology And Control, Johns Hopkins University

Paul Offit, Physician, Childrens Hospital of Pennsylvania

Derek O'Hagan, Global Head Of Discovery Support And New Technology, GSK Vaccines

Dr Saad Omer, William H. Foege Professor Of Global Health Professor Of Epidemiology And Pediatrics, Emory University - School of Medicine

Dr Dinja Oosterhoff, Principal Scientist Viral Vaccines, Intravacc

Dr Dinja Oosterhoff | Principal Scientist Viral Vaccines | Intravacc » speaking at Immune Profiling Congress

Dr Walter Orenstein, Professor And Associate Director, Emory Vaccine Center Emory University

Dr Inna Ovsyannikova, Professor Of Medicine, Mayo Foundation For Medical Education and Research

Dr Barbara Pahud, Associate Director, Vaccine And Treatment Evaluation Unit, Kansas City; Associate Professor Of Pediatrics,, Children?s Mercy Hospital

Dr Sam Pallerla, Director, CMC Monoclonal Antibody/Recombinant Protein Development, International Aids Vaccine Initiative

Dr Sam Pallerla | Director, CMC Monoclonal Antibody/Recombinant Protein Development | International Aids Vaccine Initiative » speaking at Immune Profiling Congress

Norbert Pardi, Assistant Professor, University of Pennsylvania

Norbert Pardi | Assistant Professor | University of Pennsylvania » speaking at Immune Profiling Congress

Gerald Parker, Associate Dean, Global One Health

Mark Parrington, Senior Director, Head Of External R&D, Sanofi Pasteur

Mark Parrington | Senior Director, Head Of External R&D | Sanofi Pasteur » speaking at Immune Profiling Congress

Mihir Patel, Application Specialist, Sartorius-Stedim India

Benjamin Petsch, Head Of Vaccines, CureVac Gmbh

Benjamin Petsch | Head Of Vaccines | CureVac Gmbh » speaking at Immune Profiling Congress

Grant Pickering, Chief Executive Officer, SutroVax, Inc

Grant Pickering | Chief Executive Officer | SutroVax, Inc » speaking at Immune Profiling Congress

Gerald Pier, Manager Of Medicine, Harvard Medical School

Gerald Pier | Manager Of Medicine | Harvard Medical School » speaking at Immune Profiling Congress

Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine

Gregory Poland, Director Of Mayo Vaccine Research Group, Mayo Clinic and Foundation

Dr Dale Polson, Lead, Integrated Health Systems, Boehringer Ingelheim Animal Health

Dr Dale Polson | Lead, Integrated Health Systems | Boehringer Ingelheim Animal Health » speaking at Immune Profiling Congress

Linda Powers, Chief Executive Officer, Northwest Biotherapeutics Inc

Alexander Precioso, Director, Instituto Butantan

Alexander Precioso | Director | Instituto Butantan » speaking at Immune Profiling Congress

Gregory Priebe, Associate Physician of Medicine, Children's Hospital Boston

Gregory Priebe | Associate Physician of Medicine | Children's Hospital Boston » speaking at Immune Profiling Congress

Dr Hari Pujar, Vice President Technical Development And Manufacturing, Moderna Therapeutics

Dr Samuel Rabkin, Thomas A. Pappas Professor Of Neurosciences, Department Of Neurosurgery (Microbiology And Immunology), Massachusetts General Hospital and Harvard Medical School

Dr Laszlo Radvanyi, President and Scientific Director, Ontario Institute for Cancer Research

Rino Rappuoli, Chief Scientist, GSK Vaccines

Anuja Rastogi, Clinical Associate, Food And Drug Administration

Anuja Rastogi | Clinical Associate | Food And Drug Administration » speaking at Immune Profiling Congress

Dr Dirk Redlich, Vice President Of Strategy And Operations Leader, Janssen Pharmaceutical

Dr Dirk Redlich | Vice President Of Strategy And Operations Leader | Janssen Pharmaceutical » speaking at Immune Profiling Congress

Dr Arthur Reingold, Professor And Division Head Epidemiology, Former Acip Member, UC Berkeley School of Public Health

Thomas Richie, Chief Medical Officer, Sanaria

Scot Roberts, Chief Scientific Officer, Altimmune

David Robinson, Deputy Director, Bill & Melinda Gates Foundation

David Robinson | Deputy Director | Bill & Melinda Gates Foundation » speaking at Immune Profiling Congress

Dr Jose Romero, Chair, ACIP; Professor of Pediatrics, Director, Pediatric Infectious Diseases Section, University of Arkansas for Medical Sciences

Dr Jose Romero | Chair, ACIP; Professor of Pediatrics, Director, Pediatric Infectious Diseases Section | University of Arkansas for Medical Sciences » speaking at Immune Profiling Congress

Jason Roos, Deputy Program Executive Officer, Joint Program Executive Office for Chemical and Biological Defense

Jason Roos | Deputy Program Executive Officer | Joint Program Executive Office for Chemical and Biological Defense » speaking at Immune Profiling Congress

James Rosen, President & CEO, Artizan Biosciences

Mollie Roth, Executive Director, The Microbiome Coalition

Michael Ryan, Assistant Director General, World Health Organisation

David Sack, Professor, Johns Hopkins Bloomberg School of Public Health

David Sack | Professor | Johns Hopkins Bloomberg School of Public Health » speaking at Immune Profiling Congress

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute, National Institutes of Health

David Salisbury, Director Of Immunization, UK Department of Health

Dr Daniel Salmon, Professor Global Disease Epidemiology And Control; Deputy Director Jhu?S Institute For Vaccine Safety, Johns Hopkins

Dr Mansi Saxena, Associate Scientist Vaccine And Cell Therapy Laboratory, Tisch Cancer Institute

Rami Scharf, Director, Project, Portfolio Management Centre, Vaccine Innovation And Access, PATH

Rami Scharf | Director, Project, Portfolio Management Centre, Vaccine Innovation And Access | PATH » speaking at Immune Profiling Congress

Richard Scheuermann, Director, J Craig Venter Institute

Dr John Schiller, Deputy Chief Laboratory Of Cellular Oncology, National Cancer Institute

Randal Schoepp, Department Chief, USANRIID, U.S. Army Medical Research Institute of Infectious Diseases

Randal Schoepp | Department Chief, USANRIID | U.S. Army Medical Research Institute of Infectious Diseases » speaking at Immune Profiling Congress

Michael Schrader, Co-Founder And Chief Executive Officer, Vaxess Technologies, Inc

Brent Seaton, Associate Director, Science, Q² Solutions

Brent Seaton | Associate Director, Science | Q² Solutions » speaking at Immune Profiling Congress

Channing Sebo, Technical Service Veterinarian, Merck Animal Health

Robert Seder, Chief Of Cellular Immunology Section, N.I.A.I.D. National Institutes of Health

Sanjay Sethi, Professor And Chief, Pulmonary, Critical Care And Sleep Medicine; Assistant Vice President For Health Sciences, The University at Buffalo

Aiman Shalabi, VP, Medicine Development Leader Cell Therapies R&D, NY-ESO TCR-T, GlaxoSmithKline

Angela Shen, Capt, Us Public Health Service, Senior Science Policy Advisor, National Vaccine Program Office, U.S. Department of Health & Human Services

Pei-Yong Shi, Kempner Professor Of Human Genetics, University of Texas Medical Branch

Jakub Simon, Director Clinical Research, Merck & Co

Jakub Simon | Director Clinical Research | Merck & Co » speaking at Immune Profiling Congress

Raphael Simon, Assistant Professor of Medicine, University of Maryland School of Medicine

Raphael Simon | Assistant Professor of Medicine | University of Maryland School of Medicine » speaking at Immune Profiling Congress

Dr Will Singleterry, Director Of Business Development, IsoPlexis

Andrew Skibo, Executive Vice President Of Operations, AstraZeneca

Dr Max Søgaard, Director, Process Development, ExpreS2ion Biotechnologies

Tad Sonstegard, Chief Scientific Officer, Recombinetics, Inc

Bruno Speder, Head Of Clinical Regulatory Affairs, SGS Life Science Services

Julia Spencer, Associate Vice President, Global Vaccine Public Policy, Partnerships, Merck

Dr David Spiro, Director, Division Of International Epidemiology And Population Studies (Dieps), National Institutes of Health (NIH)

Dr Pramod Srivastava, Professor Immunology And Medicine, Director Of Carole And Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine

Dr Jens-Ulrich Stegmann, Vice President Head Clinical Safety And Pharmacovigilance, G.S.K Biologicals

Dr Erin Strait, Director Of Swine Bio Research And Development For U.S., Merck & Co

Dr Erin Strait | Director Of Swine Bio Research And Development For U.S. | Merck & Co » speaking at Immune Profiling Congress

Dr Walter Straus, Associate Vice President, Therapeutic Area Head, Clinical Safety And Risk Management, Merck Research Laboratories

Dr Miriam Sturkenboom, Professor, Department Of Global Health, University Medical Center Utrecht

Dr Wenjun Sun, Vice President, JW Therapeutics

Dr Wenjun Sun | Vice President | JW Therapeutics » speaking at Immune Profiling Congress

Elizabeth Sutkowski, Chief Of Regulatory Review Branch 3, FDA

Elizabeth Sutkowski | Chief Of Regulatory Review Branch 3 | FDA » speaking at Immune Profiling Congress

Dr Nigel Swift, Global Head of Vaccine Research and Development, Boehringer Ingelheim

Dr Nigel Swift | Global Head of Vaccine Research and Development | Boehringer Ingelheim » speaking at Immune Profiling Congress

Theresa Tam, Chief Public Health Officer Of Canada, Public Health Agency of Canada

Theresa Tam | Chief Public Health Officer Of Canada | Public Health Agency of Canada » speaking at Immune Profiling Congress

Christopher Tan, Director, Business Development And Licensing, Search And Evaluation, Infectious Diseases And Vaccines, Merck

Christopher Tan | Director, Business Development And Licensing, Search And Evaluation, Infectious Diseases And Vaccines | Merck » speaking at Immune Profiling Congress

Dr Jun Tang, Senior Manager Philanthropic Venture Fund And Clinical Accelerator, Cancer Research Institute

Dr Fernanda Tavares Da Silva, Senior Director, Head Of Safety Evaluation And Risk Management, GlaxoSmithKline

Dr Graham Taylor, Senior Lecturer In Tumour Immunology, University of Birmingham

Col Deydre Teyhen, DTP, PhD, OCS, Commander, Walter Reed Army Institute Of Research

Kimberly Thompson, Former Chair, National Vaccine Advisory Committee (NVAC)

Kimberly Thompson | Former Chair | National Vaccine Advisory Committee (NVAC) » speaking at Immune Profiling Congress

Dr Steve Thorne, Chief Scientific Officer, Western Oncolytics

Sonia Timberlake, Vice President - Research And Head Of Data Science, Finch Therapeutics Group

John Treanor, Professor Of Medicine, University of Rochester

John Treanor | Professor Of Medicine | University of Rochester » speaking at Immune Profiling Congress

Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Jeffrey Ulmer, Head, Preclinical Research and Development Us, GSK Vaccines

Dr Outi Vaarala, Senior Director Research, MedImmune Inc

Dr Outi Vaarala | Senior Director Research | MedImmune Inc » speaking at Immune Profiling Congress

Dr Marit Van Buuren, Group Leader, T-Cell Immunology, Neon Therapeutics

Robert Van Den Berg, Director, GlaxoSmithKline Vaccines

Aernout Van Haarst, Director Of Scientific Affairs, Celerion

Johan Van Hoof, Global Therapeutic Area Head Of Infectious Diseases And Vaccines And Managing Director, Johnson & Johnson

Johan Van Hoof | Global Therapeutic Area Head Of Infectious Diseases And Vaccines And Managing Director | Johnson & Johnson » speaking at Immune Profiling Congress

Remko Van Leeuwen, Director Of Acquisition, Madam Therapeutics

Remko Van Leeuwen | Director Of Acquisition | Madam Therapeutics » speaking at Immune Profiling Congress

Willie Vann, Chief, Laboratory Of Bacterial Polysaccharides, Cber, FDA

Dr Jonathan Van-Tam, Deputy Chief Medical Officer, UK Department of Health

Rajeev Venkayya, Executive Vice President, Vaccine Business, Takeda Pharmaceuticals International, Inc

Rajeev Venkayya | Executive Vice President, Vaccine Business | Takeda Pharmaceuticals International, Inc » speaking at Immune Profiling Congress

Annette Vogel, Head Of Infectious Disease Vaccines, BioNtech

Annette Vogel | Head Of Infectious Disease Vaccines | BioNtech » speaking at Immune Profiling Congress

Dr I Ming Wang, Director, Pfizer

Dr Brian Ward, Medical Officer, Medicago

Jim Wassil, Vice President, Business Unit Lead, Vaccines, Global Health And Value, Pfizer

Stephen Waterman, Managing Director, PharmaVentures Ltd

Stephen Waterman | Managing Director | PharmaVentures Ltd » speaking at Immune Profiling Congress

Mike Watson, Senior Vice President, Moderna Therapeutics

Mike Watson | Senior Vice President | Moderna Therapeutics » speaking at Immune Profiling Congress

Patrick Wedlock, Research Associate, Johns Hopkins Bloomberg School of Public Health

David Weiner, Professor And Ww Smith Chair In Cancer Research Director Wistar Vaccine Center And Executive Vice President, The Wistar Institute

David Weiner | Professor And Ww Smith Chair In Cancer Research  Director Wistar Vaccine Center And Executive Vice President | The Wistar Institute » speaking at Immune Profiling Congress

Dr Charlie Weller, Head Of Vaccines Programme, Wellcome Trust

Deborah Whitmer, Chief of Staff, U.S. Army Medical Research and Materiel Command

Deborah Whitmer | Chief of Staff | U.S. Army Medical Research and Materiel Command » speaking at Immune Profiling Congress

Adrian Wildfire, Project Director - Infectious Diseases And Viral Infection Unit, SGS Life Science Services

Dr Stacey Wooden, Scientific Advisor, The Human Vaccines Project

Dr Stacey Wooden | Scientific Advisor | The Human Vaccines Project » speaking at Immune Profiling Congress

Scott Woollens, AVP, Regulatory Affairs-Vaccines CMC, Merck

Scott Woollens | AVP, Regulatory Affairs-Vaccines CMC | Merck » speaking at Immune Profiling Congress

Darin Zehrung, Portfolio Leader Of Vaccine And Pharmaceutical Delivery Technologies And Senior Technical Officer, Path

Sign Up for Event Updates